Clinical Profile and Outcomes of Rheumatic Heart Disease Patients Undergoing Surgical Valve Procedures in Uganda
Rwebembera J, Chang A, Kitooleko S, Kaudha G, de Loizaga S, Nalule M, Ahabwe K, Zhang W, Okello E, Sinha P, Mwambu T, Sable C, Beaton A, Longenecker C. Clinical Profile and Outcomes of Rheumatic Heart Disease Patients Undergoing Surgical Valve Procedures in Uganda. Global Heart 2023, 18: 62. PMID: 38028964, PMCID: PMC10655755, DOI: 10.5334/gh.1260.Peer-Reviewed Original ResearchConceptsRheumatic heart diseaseAcute rheumatic feverComplication of acute rheumatic feverHeart diseaseValve surgery proceduresPost-operative survivalCohort of patientsProportion of patientsOutcome of operated patientsRetrospective cohort studyFifteen-year survivalValvular heart diseaseChronic valvular heart diseaseLong-term complicationsMortality of patientsValve surgeryValve repairValvular operationsValve proceduresPublic health problemRe-operationValve replacementSurgical managementUgandan patientsValvular interventionsAbstract 14916: Clinical and Socioeconomic Factors Associated With Time to Surgery and Preoperative Mortality in Surgery-Eligible Patients With Rheumatic Valvular Heart Disease in Uganda
Doh C, An C, Chang A, Rwebembera J, Mwambu T, Beaton A, Nakagaayi D, Vega P, Sable C, Lwabi P, Longenecker C. Abstract 14916: Clinical and Socioeconomic Factors Associated With Time to Surgery and Preoperative Mortality in Surgery-Eligible Patients With Rheumatic Valvular Heart Disease in Uganda. Circulation 2023, 148: a14916-a14916. DOI: 10.1161/circ.148.suppl_1.14916.Peer-Reviewed Original ResearchRheumatic heart diseaseFactors associated with timeLikelihood of surgeryPreoperative mortalitySurgical indicationsAwaiting surgeryAtrial fibrillationIncreased likelihood of surgeryValvular rheumatic heart diseaseHistory of infective endocarditisHistory of atrial fibrillationMultivariate Cox proportional hazards modelAdvanced rheumatic heart diseaseHeart diseaseRate of surgical interventionRheumatic valvular heart diseaseNYHA class I/IISurgery-eligible patientsNYHA class III/IVMedian follow-upAssociated with increased mortalityTime to surgeryCohort of patientsReceipt of surgeryValvular heart disease